Diagnostic Algorithm to Differentiate Benign Atypical Leiomyomas from Malignant Uterine Sarcomas with Diffusion-weighted MRI
- PMID: 32930650
- DOI: 10.1148/radiol.2020191658
Diagnostic Algorithm to Differentiate Benign Atypical Leiomyomas from Malignant Uterine Sarcomas with Diffusion-weighted MRI
Erratum in
-
Diagnostic Algorithm to Differentiate Benign Atypical Leiomyomas from Malignant Uterine Sarcomas with Diffusion-weighted MRI.Radiology. 2020 Dec;297(3):E347. doi: 10.1148/radiol.2020209020. Radiology. 2020. PMID: 33196375 No abstract available.
Abstract
Background Improving the differentiation of uterine sarcomas from atypical leiomyomas remains a clinical challenge and is needed to avoid inappropriate surgery. Purpose To develop a diagnostic algorithm including diffusion-weighted MRI criteria to differentiate malignant uterine sarcomas from benign atypical leiomyomas. Materials and Methods This case-control retrospective study identified women with an atypical uterine mass at MRI between January 2000 and April 2017, with surgery or MRI follow-up after 1 year or longer. A diagnostic algorithm including T2-weighted MRI and diffusion-weighted imaging (DWI) signal and apparent diffusion coefficient (ADC) values was developed to predict for sarcoma. The training set consisted of 51 sarcomas and 105 leiomyomas. Two external validation sets were used to evaluate interreader reproducibility (16 sarcomas; 26 leiomyomas) and impact of reader experience (29 sarcomas; 30 leiomyomas). Wilson confidence intervals (CIs) were calculated for sensitivity and specificity. Results Evaluated were 156 women (median age, 50 years; interquartile range, 44-63 years). Predictive MRI criteria for malignancy were enlarged lymph nodes or peritoneal implants, high DWI signal greater than that in endometrium, and ADC less than or equal to 0.905 × 10-3 mm2/sec. Conversely, a global or focal area of low T2 signal intensity and a low or an intermediate DWI signal less than that in endometrium or lymph nodes allowed readers to confidently diagnose as benign a uterine mass demonstrating one or more of these signs (P < .001) in 100% cases in all three data sets. The sensitivities and specificities of the algorithm for diagnosis of malignancy were 98% (50 of 51 masses; 95% CI: 90%, 100%) and 94% (99 of 105 masses; 95% CI: 88%, 98%) in the training set; 88% (14 of 16 masses; 95% CI: 64%, 97%) and 100% (26 of 26 masses; 95% CI: 87%, 100%) in the validation set; and 83% (24 of 29 masses; 95% CI: 65%, 92%) and 97% (29 of 30 masses; 95% CI: 83%, 99%) for the less experienced reader, respectively. Conclusion A diagnostic algorithm with predictive features including lymphadenopathy, high diffusion-weighted imaging signal with reference to endometrium, and low apparent diffusion coefficient enabled differentiation of malignant sarcomas from atypical leiomyomas, and it may assist inexperienced readers. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by Méndez in this issue.
Comment in
-
MRI to Differentiate Atypical Leiomyoma from Uterine Sarcoma.Radiology. 2020 Nov;297(2):372-373. doi: 10.1148/radiol.2020203322. Epub 2020 Sep 15. Radiology. 2020. PMID: 32936067 No abstract available.
Similar articles
-
Uterine Sarcoma or Degenerating Fibroid? Validating the New Consensus Magnetic Resonance Imaging Algorithm for Evaluating Atypical Uterine Masses.J Comput Assist Tomogr. 2025 Jan-Feb 01;49(1):57-63. doi: 10.1097/RCT.0000000000001656. Epub 2024 Oct 4. J Comput Assist Tomogr. 2025. PMID: 39379060
-
Preoperative diagnosis of atypical pelvic leiomyoma and sarcoma: the potential role of diffusion-weighted imaging.J Obstet Gynaecol. 2019 Jan;39(1):98-104. doi: 10.1080/01443615.2018.1466110. Epub 2018 Sep 12. J Obstet Gynaecol. 2019. PMID: 30207503
-
Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas.Eur Radiol. 2009 Nov;19(11):2756-64. doi: 10.1007/s00330-009-1471-x. Epub 2009 Jun 6. Eur Radiol. 2009. PMID: 19504102
-
Utility of ADC Values for Differentiating Uterine Sarcomas From Leiomyomas: Systematic Review and Meta-Analysis.AJR Am J Roentgenol. 2024 Sep;223(3):e2431280. doi: 10.2214/AJR.24.31280. Epub 2024 Jun 5. AJR Am J Roentgenol. 2024. PMID: 38899844
-
Uterine fibroid-like tumors: spectrum of MR imaging findings and their differential diagnosis.Abdom Radiol (NY). 2022 Jun;47(6):2197-2208. doi: 10.1007/s00261-022-03431-6. Epub 2022 Mar 26. Abdom Radiol (NY). 2022. PMID: 35347386 Review.
Cited by
-
Advances in the Preoperative Identification of Uterine Sarcoma.Cancers (Basel). 2022 Jul 20;14(14):3517. doi: 10.3390/cancers14143517. Cancers (Basel). 2022. PMID: 35884577 Free PMC article. Review.
-
Differentiating Uterine Sarcoma From Atypical Leiomyoma on Preoperative Magnetic Resonance Imaging Using Logistic Regression Classifier: Added Value of Diffusion-Weighted Imaging-Based Quantitative Parameters.Korean J Radiol. 2024 Jan;25(1):43-54. doi: 10.3348/kjr.2023.0760. Korean J Radiol. 2024. PMID: 38184768 Free PMC article.
-
Highly Cellular Leiomyoma Mixed With a Focus of Adenomyosis.Cureus. 2022 Aug 18;14(8):e28129. doi: 10.7759/cureus.28129. eCollection 2022 Aug. Cureus. 2022. PMID: 35999995 Free PMC article.
-
Quantitative MR texture analysis for the differentiation of uterine smooth muscle tumors with high signal intensity on T2-weighted imaging.Medicine (Baltimore). 2023 Aug 4;102(31):e34452. doi: 10.1097/MD.0000000000034452. Medicine (Baltimore). 2023. PMID: 37543807 Free PMC article.
-
Diagnostic interpretation of non-contrast qualitative MR imaging features for characterisation of uterine leiomyosarcoma.Br J Radiol. 2021 Sep 1;94(1125):20210115. doi: 10.1259/bjr.20210115. Epub 2021 Jun 16. Br J Radiol. 2021. PMID: 34111973 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous